Jump to content
IGNORED

India court rejects Novartis plea for cancer drug patent


News Bandit

Recommended Posts

New Delhi - India's Supreme Court Monday dismissed Swiss drugmaker Novartis AG's appeal seeking patent protection for its popular leukemia drug Glivec, a ruling seen as a major blow for global drug firms.

 

View the full article

Link to comment
Share on other sites

Three cheers for India's Supreme Court.

I did not know her name, I did not know her name but I sure did love the way she laughed and called me honey.

I did not know her name, I did not know her name but I sure did love the way she laughed and took my money.

Link to comment
Share on other sites

This is actually a big deal. Drug companies will no longer be able to 'evergreen' patents via minor variations.

Link to comment
Share on other sites

This is actually a big deal. Drug companies will no longer be able to 'evergreen' patents via minor variations.

 

That could have be an argument if the original drug had received a patent, but that one was also denied.

Link to comment
Share on other sites

Some years ago the Indian High Court also rejected  an appeal from Phiser about an Indian company making a 'copy' of Viagra called Kamagra.

 

Later Kamagra changed the color from blue to green as a sop to Phiser but kept the Viagra size and shape.

 

 

Recently a Thai company have started manufacturing "copies' called Sidegra.(available in 50mg or 100 mg.)

Sex without love is an empty experience;

 

But as empty experiences go, it is one of the best.

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.



  • COVID-19

    Any posts or topics which the moderation team deems to be rumours/speculatiom, conspiracy theory, scaremongering, deliberately misleading or has been posted to deliberately distort information will be removed - as will BMs repeatedly doing so. Existing rules also apply.

  • Advertise on Pattaya Addicts
  • Recently Browsing

    • No registered users viewing this page.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.